SCHEMBL2722927

SCHEMBL2722927

Brc1coc(-c2cccnc2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 8/20 0.48
CYP3A4 P08684 4/20 0.48
ALDH1A1 P00352 3/20 0.48
CYP1A2 P05177 1/20 0.48
CYP11B1 P15538 1/20 0.47
CYP11B2 P19099 1/20 0.47
CYP2E1 P05181 4/20 0.42
CYP2C9 P11712 4/20 0.42
CYP2B6 P20813 4/20 0.42
CYP2C19 P33261 4/20 0.42
CYP2D6 P10635 3/20 0.42
KDM4E B2RXH2 2/20 0.42
HPGD P15428 2/20 0.42
HSD17B10 Q99714 2/20 0.42
TP53 P04637 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
LMNA P02545 1/20 0.42
MAPT P10636 1/20 0.42
ALOX15 P16050 1/20 0.42
HTT P42858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21249399 0.79 CYP19A1 (0.51) CYP2A6CYP3A4ALDH1A1CYP1A2CYP11B1
SCHEMBL15219313 0.79 CYP2A6 (0.49) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2E1
SCHEMBL4474507 0.77 PTK2 (0.45) CYP11B1KDM4ETP53SMN1; SMN2LMNA
SCHEMBL12100428 0.77 ALDH1A1 (0.42) ALDH1A1TP53SMN1; SMN2MEN1KMT2A
SCHEMBL6194452 0.76 CYP3A4 (0.55) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2E1
SCHEMBL27605054 0.76 KMO (0.49) CYP2A6CYP3A4ALDH1A1CYP1A2CYP11B1
SCHEMBL22515427 0.75 CYP2A6 (0.44) CYP2A6CYP3A4ALDH1A1CYP1A2CYP11B1
SCHEMBL363026 0.75 KMO (0.59) CYP2A6CYP3A4ALDH1A1CYP1A2CYP11B1
SCHEMBL11916005 0.75 KIF11 (0.56) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2E1
SCHEMBL12765974 0.73 CYP11B1 (0.43) CYP11B1CYP11B2ALOX15MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150373978-A1 NOVEL HETEROCYCLIC COMPOUNDS AS PESTICIDES BAYER IP GMBH (DE) 2015-12-31 US disclosed
US-20150373978-A1 NOVEL HETEROCYCLIC COMPOUNDS AS PESTICIDES BAYER IP GMBH (DE) 2015-12-31 US disclosed
US-20150373978-A1 NOVEL HETEROCYCLIC COMPOUNDS AS PESTICIDES BAYER IP GMBH (DE) 2015-12-31 US disclosed
US-9173396-B2 Heterocyclic compounds as pesticides BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-11-03 US disclosed
US-9173396-B2 Heterocyclic compounds as pesticides BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-11-03 US disclosed
US-9173396-B2 Heterocyclic compounds as pesticides BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-11-03 US disclosed
US-20130261141-A1 NOVEL HETEROCYCLIC COMPOUNDS AS PESTICIDES BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-10-03 US disclosed
US-20130261141-A1 NOVEL HETEROCYCLIC COMPOUNDS AS PESTICIDES BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-10-03 US disclosed
US-20130261141-A1 NOVEL HETEROCYCLIC COMPOUNDS AS PESTICIDES BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-10-03 US disclosed
EP-2630133-A1 NOVEL HETEROCYCLIC COMPOUNDS AS PESTICIDES Bayer Intellectual Property GmbH (DE) 2013-08-28 EP disclosed
WO-2012052412-A1 NOVEL HETEROCYCLIC COMPOUNDS AS PESTICIDES BAYER CROPSCIENCE AG (DE) 2012-04-26 WO disclosed
WO-2012052412-A1 NOVEL HETEROCYCLIC COMPOUNDS AS PESTICIDES BAYER CROPSCIENCE AG (DE) 2012-04-26 WO disclosed
US-7514567-B2 Oxazolidinone nicotinic acetylcholine receptor agonists ASTRAZENECA AB (SE) 2009-04-07 US disclosed
US-7514567-B2 Oxazolidinone nicotinic acetylcholine receptor agonists ASTRAZENECA AB (SE) 2009-04-07 US disclosed
US-7514567-B2 Oxazolidinone nicotinic acetylcholine receptor agonists ASTRAZENECA AB (SE) 2009-04-07 US disclosed
CN-1829721-A Spiro '1-azabicyclo' 2.2.2! octan-3,5'-oxazolidin - 2'-one! derivatives with affinity to the alpha7 nicotinic acetylcholine receptor ASTRAZENECA AB (SE) 2006-09-06 CN disclosed
US-20060154945-A1 Spiro '1-azabicyclo' 2.2.2! octan-3,5'-oxazolidin - 2'-one! derivatives with affinity to the alpha7 nicotinic acetylcholine receptor ASTRAZENECA AB (SE) 2006-07-13 US disclosed
EP-1654264-A1 SPIRO [1-AZABICYCLO [2.2.2]OCTANE-3,5'-OXAZOLIDIN-2'-ONE] DERIVATIVES WITH AFFINITY TO THE ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR AstraZeneca AB (SE) 2006-05-10 EP disclosed
WO-2005005435-A1 SPIRO ′1-AZABICYCLO ′2.2.2!OCTAN-3,5′-OXAZOLIDIN -2′-ONE! DERIVATIVES WITH AFFINITY TO THE ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR ASTRAZENECA AB (SE) 2005-01-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060154945-A1 Spiro '1-azabicyclo' 2.2.2! octan-3,5'-oxazolidin - 2'-one! derivatives with affinity to the alpha7 nicotinic acetylcholine receptor CHRNA1, CHRNA7, ADRA1D CYP2A6 817/4885CYP3A4 1372/4885ALDH1A1 213/4885
US-20130261141-A1 NOVEL HETEROCYCLIC COMPOUNDS AS PESTICIDES DDT, ACHE, PTMS CYP2A6 853/4885CYP3A4 317/4885ALDH1A1 2666/4885
US-20150373978-A1 NOVEL HETEROCYCLIC COMPOUNDS AS PESTICIDES DDT, ACHE, PTMS CYP2A6 853/4885CYP3A4 317/4885ALDH1A1 2666/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.